Company / Operating Cash Flow per Share
10x Genomics, Inc. Operating Cash Flow per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$1.11
FY2025
5-year range
-$0.30 / $1.11
FY2021-FY2025
Trend
+1888.2%
vs FY2024
Sector context
#109 of 155
Health Care
What the data says
Operating Cash Flow per Share changed +1888% YoY in FY2025, a notable deviation from the 8-year average annual change of +194%.
Based on SEC 10-K filings.
1.11 in FY2025.
Improved from $-0.13 to $1.11 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#109 of 155 in Health CareTop 70% of 155This company $1.11 Sector average $6.77
▼
-83.6% below sector average
Key checks
Key Insights
- 10x Genomics, Inc.'s operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 1888.2% year-over-year.
- Ranks #109 out of 155 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.11 | +1888.2% |
| FY2024 | $0.06 | +142.4% |
| FY2023 | -$0.13 | +55.8% |
| FY2022 | -$0.30 | -51.6% |
| FY2021 | -$0.20 | +91.3% |
| FY2020 | -$2.26 | -195.1% |
| FY2019 | $2.38 | +141.7% |
| FY2018 | -$5.71 | -517.9% |
| FY2017 | -$0.92 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026